BIBF 1120 for Recurrent High-Grade Gliomas

NCT01380782 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Gliosarcoma
Anaplastic Astrocytoma
Anaplastic Oligodendroglioma
Anaplastic Oligoastrocytoma

Interventions

DRUG: BIBF 1120

Sponsor

Patrick Y. Wen, MD

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]